bromofosfamide has been researched along with ifosfamide in 8 studies
*Ifosfamide: Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. [MeSH]
*Ifosfamide: Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. [MeSH]
| Studies (bromofosfamide) | Trials (bromofosfamide) | Recent Studies (post-2010) (bromofosfamide) | Studies (ifosfamide) | Trials (ifosfamide) | Recent Studies (post-2010) (ifosfamide) |
|---|---|---|---|---|---|
| 9 | 1 | 0 | 5,045 | 1,430 | 1,113 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kinas, RW; Kusnierczyk, H; Misiura, K; Radzikowski, C; Sonoda, A; Stec, WJ | 1 |
| Ciesielska, E; Kinas, R; Studzian, K; Szmigiero, L | 1 |
| Kusnierczyk, H; Pajtasz-Piasecka, E; Radzikowski, C | 1 |
| Kinas, RW; Kuśnierczyk, H; Misiura, K; Radzikowski, C; Stec, WJ | 1 |
| Kobylińska, K; Kobylińska, M; Sobik, B | 1 |
| Gasiorek, M; Kobylińska, K; Kobylińska, M; Koralewski, P; Sobik, B | 1 |
| Misiura, K | 2 |
1 review(s) available for bromofosfamide and ifosfamide
| Article | Year |
|---|---|
[Oxazaphosphorinane drugs. New analogues, metabolic studies, and therapeutic approaches].
Topics: Animals; Antineoplastic Agents; Genetic Therapy; Humans; Ifosfamide | 2004 |
1 trial(s) available for bromofosfamide and ifosfamide
| Article | Year |
|---|---|
Pharmacokinetics and toxicity of oral (-)-(S)-bromofosfamide in lung cancer patients.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Blood Cell Count; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Spectrophotometry, Ultraviolet | 2001 |
6 other study(ies) available for bromofosfamide and ifosfamide
| Article | Year |
|---|---|
Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Female; Ifosfamide; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Structure-Activity Relationship | 1988 |
Effects of alkylating metabolites of ifosfamide and its bromo analogues on DNA of HeLa cells.
Topics: Cell Division; Cell Survival; Cross-Linking Reagents; DNA, Neoplasm; Dose-Response Relationship, Drug; HeLa Cells; Humans; Ifosfamide; Phosphoramide Mustards | 1992 |
Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Colonic Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Synergism; Female; Ifosfamide; Immunotherapy, Adoptive; Interleukin-2; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Plasmacytoma; Tumor Cells, Cultured | 1999 |
(S)-(-)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Biological Availability; Carcinoma, Lewis Lung; Chromatography, High Pressure Liquid; Crosses, Genetic; Female; Ifosfamide; Injections, Subcutaneous; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Structure | 2001 |
Pharmacokinetics of (-)-(S)-bromofosfamide after intravenous and oral administration in mice.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Female; Half-Life; Ifosfamide; Injections, Intravenous; Mice; Spectrophotometry, Ultraviolet | 2001 |
Synthesis of potential metabolites of (S)-(-)-bromofosfamide.
Topics: Antineoplastic Agents, Alkylating; Biotransformation; Chromatography, Thin Layer; Ifosfamide; Magnetic Resonance Spectroscopy; Stereoisomerism | 2004 |